Exhibit 99.1 Caris Life Sciences Reports First Quarter 2026 Financial Results Revenue growth of 79% driven by strong performance in molecular profiling services IRVING, Texas, May 07, 2026— Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient centric, next-generation AI TechBio company and precision medicine pioneer, today reported financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights "We delivered another strong quarter with record performance for February a ...